Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

Although the stock market was having a generally strong week, that isn't the case for vaccine technology company Moderna ...

BioNTech and Moderna COVID-19 vaccines use mRNA technology in their vaccines to protect us from the spread of the disease.

Moderna MRNA provided an update on its financial outlook and pipeline progress at the J.P. Morgan Healthcare Conference. At ...

RFK Jr., who's nominated to become the next health secretary, asked the federal government to revoke its authorization of all ...

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...

The FDA recently issued draft guidances for the use of AI in medical devices, drugs, and biologics. The guidances emphasize the need for comprehensive AI policies addressing risk evaluation ...

On January 7, 2024, the U.S. Food and Drug Administration (FDA) published the draft guidance “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing ...

With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of ... probably at least in part because of coronavirus-related lockdowns, coming in 13 cases in 2020 and 49 in ...

Tests seemed to indicate that this would easily allow it to evade the immune protection offered by past infections or the latest iterations of the Covid-19 vaccines, based on the older JN.